Core Scientific, Inc. $CORZ Shares Sold by Aurelius Capital Management LP

Aurelius Capital Management LP cut its holdings in Core Scientific, Inc. (NASDAQ:CORZ) by 47.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 674,452 shares of the company’s stock after selling 602,525 shares during the period. Core Scientific accounts for about 51.6% of Aurelius Capital Management LP’s holdings, making the stock its biggest position. Aurelius Capital Management LP owned 0.23% of Core Scientific worth $4,883,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CORZ. Wells Fargo & Company MN raised its holdings in Core Scientific by 41.7% in the 4th quarter. Wells Fargo & Company MN now owns 100,848 shares of the company’s stock valued at $1,417,000 after acquiring an additional 29,669 shares during the last quarter. Envestnet Asset Management Inc. acquired a new position in Core Scientific in the 4th quarter valued at $1,707,000. Bank of Montreal Can acquired a new position in Core Scientific in the 4th quarter valued at $142,000. Guggenheim Capital LLC acquired a new position in Core Scientific in the 4th quarter valued at $234,000. Finally, First Trust Advisors LP increased its holdings in shares of Core Scientific by 33.0% during the 4th quarter. First Trust Advisors LP now owns 203,036 shares of the company’s stock worth $2,853,000 after buying an additional 50,331 shares during the last quarter.

Wall Street Analysts Forecast Growth

CORZ has been the subject of a number of research analyst reports. Oppenheimer restated a “market perform” rating on shares of Core Scientific in a report on Monday, July 7th. Canaccord Genuity Group restated a “buy” rating and set a $17.00 price objective on shares of Core Scientific in a report on Friday, June 27th. Macquarie restated a “neutral” rating and set a $15.00 price objective on shares of Core Scientific in a report on Tuesday. Arete started coverage on Core Scientific in a report on Tuesday, July 22nd. They issued a “buy” rating and a $20.00 price target for the company. Finally, HC Wainwright reiterated a “neutral” rating on shares of Core Scientific in a report on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Core Scientific has an average rating of “Hold” and a consensus target price of $18.32.

Insider Activity

In other Core Scientific news, Director Yadin Rozov acquired 110,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 28th. The shares were purchased at an average price of $10.87 per share, for a total transaction of $1,195,700.00. Following the completion of the purchase, the director directly owned 475,687 shares in the company, valued at $5,170,717.69. The trade was a 30.08% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Todd M. Duchene sold 60,000 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $11.33, for a total transaction of $679,800.00. Following the sale, the insider owned 2,100,102 shares in the company, valued at approximately $23,794,155.66. This trade represents a 2.78% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 117,759 shares of company stock worth $1,391,434 in the last ninety days. Corporate insiders own 1.40% of the company’s stock.

Core Scientific Price Performance

NASDAQ:CORZ opened at $13.55 on Friday. The firm has a 50-day moving average of $13.97 and a two-hundred day moving average of $11.08. The stock has a market cap of $4.14 billion, a P/E ratio of -24.20 and a beta of 6.60. Core Scientific, Inc. has a 1-year low of $6.20 and a 1-year high of $18.63.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Friday, August 8th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.07) by $0.03. The company had revenue of $78.63 million for the quarter, compared to the consensus estimate of $82.09 million. The firm’s revenue for the quarter was down 44.3% compared to the same quarter last year. As a group, equities analysts expect that Core Scientific, Inc. will post 0.52 earnings per share for the current year.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.